Medical Supply Ureteroscopy

Dornier Medtech

Payments companies reported to CMS as associated with Dornier Medtech. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.8Massociated payments (2023-2025)

369clinicians with associated payments

4companies reporting

By year

2023 $34K

2024 $877K

2025 $841K

Payments reported as associated with Dornier Medtech, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Urology $1.7M

Physician Assistant $1,143

Surgery $821

Nurse Practitioner $656

Transplant Surgery $418

Family $293

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Dornier Medtech

These are the largest totals companies reported as associated with Dornier Medtech. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Brian Orr	Greenwood, IN	Urology	$144,509.62
Bradley Orris	Greenwood, IN	Urology	$88,492.02
Jason Sprunger	Indianapolis, IN	Urology	$88,285.72
Matthew Tellman	Fishers, IN	Urology	$88,285.72
Charles Schwab	Greenwood, IN	Urology	$88,285.72
David Gilley	Greenwood, IN	Urology	$88,285.72
Alexander Tatem	Carmel, IN	Urology	$88,285.72
James Raybourn	Greenwood, IN	Urology	$88,285.72
Weston Kitley	Greenwood, IN	Urology	$88,285.72
Daniel Salvas	Franklin, IN	Urology	$88,285.72

Prescribed Dornier Medtech?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.